Acrivon Therapeutics, Inc. Common Stock Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ADAG
|
Adagene Inc. | $2.93 | $131.46 M | -6.77 | 174 | $18.11 M |
 ANAB
|
AnaptysBio, Inc. | $19.40 | $640.07 M | -3.82 | 117 | $17.16 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.87 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.10 | $60.55 M | -0.81 | 41 | $0 |
 AVTE
|
Aerovate Therapeutics, Inc. | $2.64 | $597.48 M | -6.84 | 51 | $0 |
 MLYS
|
Mineralys Therapeutics, Inc. | $13.61 | $652.38 M | -6.03 | 28 | $0 |
|
MOLN
|
Molecular Partners AG | $5.74 | $135.05 M | -2.03 | 167 | $7.04 M |
 OPT
|
Opthea Limited | $4.24 | $214.34 M | -1.04 | 33 | $125,122 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.64 | $85.40 M | -1.26 | 63 | $0 |
 RZLT
|
Rezolute, Inc. | $5.51 | $229.57 M | -5.02 | 51 | $0 |